Clinical Trials Sponsored by Retina Global

Total 1727 results

MidAtlantic Retina
Regeneron Pharmaceuticals

Completed

Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration (ATLAS)

Age-Related Macular Degeneration | Macular Degeneration

United States
Southeast Retina Center, Georgia
Genentech, Inc.

Unknown

Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab (ROTATE)

Diabetic Macular Edema

United States
Northern California Retina Vitreous Associates
Allergan

Completed

Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery

Diabetic Macular Edema | Pseudophakic Cystoid Macular Edema,

United States
Retina Institute of Hawaii
Genentech, Inc.

Completed

Lucentis for Treatment of Macular Edema (FVF4153s)

Cystoid Macular Edema

United States
Retina Consultants of Hawaii
Genentech, Inc.

Unknown

Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy (PEARL2)

Polypoidal Choroidal Vasculopathy

United States
Bay Area Retina Associates
QLT Inc.

Completed

Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration (PDEX)

Age Related Macular Degeneration

United States
Global Kinetics Corporation

Recruiting

Personal KinetiGraph® Clinical Validation Study

Parkinson Disease | Movement Disorders

United States
Global Neurosciences Institute

Recruiting

Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme

Glioblastoma Multiforme

United States
ProgenaCare Global, LLC

Active, not recruiting

Efficacy of ProgenaMatrix™ in the Management of DFUs

Diabetic Foot Ulcer

United States
Global Kinetics Corporation

Withdrawn

Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG (TARGET-PwP)

Parkinson Disease
Global Surgery Amsterdam

Completed

From Short-term Surgical Missions Towards Sustainable Partnerships

Global Surgery | Medical Missions

Netherlands
Global Blood Therapeutics

Terminated

Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest (Zephyr)

Idiopathic Pulmonary Fibrosis | Hypoxemia

United Kingdom, United States
Global Blood Therapeutics

Completed

Single-Dose PK Study of GBT440 in Subjects With Renal Impairment

Renal Impairment

United States
Global Blood Therapeutics

Completed

A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects

Sickle Cell Disease

United States
Global Blood Therapeutics

Completed

A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects

Anemia, Sickle Cell

United States
Southeast Retina Center, Georgia
Genentech, Inc.

Completed

Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy

United States
MidAtlantic Retina
Alcon Research

Completed

Comparision of Retinal Surgery by Three-dimensional Heads-up Display to the Standard Operating Microscope

Comparison of 3D Visualization and Microscope for VR Surgery

United States
Rocky Mountain Retina Consultants
Genentech, Inc.

Completed

Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

United States
Retina Associates, Kansas City
Genentech, Inc.

Unknown

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

Proliferative Diabetic Retinopathy

United States
Alexander Eaton
California Retina Consultants; Konowal Vision Center; Southwest Florida Eye Care

Unknown

Eye Drop Application Monitor, Pilot Study

Glaucoma | Cataracts | Retina Surgery | Any Condition That Requires Ophthalmic Drops

United States
Texas Retina Associates
Eye Point Pharmaceuticals

Recruiting

The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment (TYNI)

Uveitis, Anterior | Uveitis | Uveitis, Posterior | Uveitis, Intermediate

United States
Greater Houston Retina Research
Genentech, Inc.

Active, not recruiting

Safety and Efficacy of Faricimab in Patients With NPDR (MAGIC)

Non-Proliferative Diabetic Retinopathy

United States
Southern California Desert Retina Consultants, MC

Completed

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration (PREVENT)

Age-related Macular Degeneration

United States
Greater Houston Retina Research
Genentech, Inc.

Completed

Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. (RRR)

Radiation Retinopathy

United States
New England Retina Associates
Genentech, Inc.

Completed

Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)

Choroidal Melanoma

United States
Northern California Retina Vitreous Associates
Allergan

Completed

TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema

Uveitis | Macular Edema

United States
Southeast Retina Center, Georgia
Regeneron Pharmaceuticals

Unknown

Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial) (RIVAL)

Neovascular Polypoidal Choroidal Vasculopathy

United States
Retina Institute of Hawaii
Eyetech Pharmaceuticals

Available

A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema (GUARDIAN)

Diabetic Macular Edema

United States
Retina Associates of Kentucky
Genentech, Inc.

Unknown

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome (IVL for OHS)

Ocular Histoplasmosis Syndrome

United States
The National Retina Institute
Genentech, Inc.

Completed

Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration

Macular Degeneration

United States
Global Aesthetics LLC

Recruiting

Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation

Wrinkle

United States
Zoe Global Limited

Active, not recruiting

ZOE's Ferment Experiment (ZHS-FE)

Mood | Hunger | Energy

United Kingdom
Global Kinetics Corporation

Active, not recruiting

Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status (APPRISE)

Parkinson Disease

United States
Aspen Global Incorporated

Terminated

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban (HITSOVA)

Heparin-induced Thrombocytopenia

United States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
Global Kinetics Corporation

Terminated

Utilization of Target Ranges to Treat Parkinson's Disease With the PKG (TARGET-PD)

Parkinson Disease

United States
Global Blood Therapeutics

Completed

Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF

Idiopathic Pulmonary Fibrosis | Hypoxemia

United States
WCCT Global
Vaxart

Completed

Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model

Norovirus Infection

United States
Aspen Global Incorporated

Completed

A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.

Injection Site Reaction
Global Blood Therapeutics

Completed

An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001

Sickle Cell Disease

United Kingdom
Global Blood Therapeutics

Completed

A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease

Sickle Cell Disease | Healthy Subjects

United Kingdom
Global Blood Therapeutics

Completed

Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects

Sickle Cell Disease

United States
MedLogic Global Limited

Completed

Clinical Trial of MedLogic LiquiBand Laparoscopic Versus Dermabond in the Closure of Surgical Incisions

Laparoscopic Surgery

United Kingdom
Regina Elena Cancer Institute

Recruiting

Analysis and Evaluation of Smoking Treatment With Cytisine

Moderate or Severe Tobacco Use Disorder

Italy
Regina Elena Cancer Institute

Recruiting

Tolerability and Efficacy of Adjuvant T-DM1 in Patients With HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents. Real-world Multicenter Retrospective-prospective Study (ATD)

Breast Cancer

Italy
Regina Elena Cancer Institute

Recruiting

Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies (Telenursing)

Melanoma | Lung Neoplasm

Italy
Regina Elena Cancer Institute

Recruiting

External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients (ESIBIRE)

Breast Cancer | Breast Neoplasms

Italy
Regina Elena Cancer Institute

Recruiting

Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment (AATF/Che-1)

Multiple Myeloma

Italy
Regina Elena Cancer Institute

Recruiting

Psyco Quality of Life and Procreation BRCA1/2 (QoL)

Breast Cancer | Genetic Predisposition

Italy
Regina Elena Cancer Institute

Recruiting

Single-cell RNAseq Breast Cancer (SCRBC)

Breast Neoplasms

Italy
Regina Elena Cancer Institute

Recruiting

Prognostic Relevance of Coagulation Activation in RIsk Assessment and Stratification (ARIAS)

Local Cancer

Italy

Clinical Trials Sponsored by Retina Global

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations